Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about RiverVest, Novo Ventures, Other Lead $86M Series A IN Tioma Therapeutics
Venture Capital

RiverVest, Novo Ventures, Other Lead $86M Series A IN Tioma Therapeutics

by marketwired.com posted 2years ago 953 views
The Series A financing was co-led by RiverVest Venture Partners (including 3x5 RiverVest Fund), Novo Ventures, Roche Venture Fund and S.R. One, Limited (the corporate venture capital arm of GlaxoSmithKline).

In this article